Scrip
Two appointments at Chimerix
22 July 2010
Zoe Dann
Please Login to read the full article.
22 July 2010
Zoe Dann
zoe.dann@informa.com
Chimerix, a US biotechnology company developing antiviral therapeutics, has appointed
Timothy King vice-president of clinical operations and
Dr Hervé Momméja-Marin vice-president of clinical research. Mr King has more than 20 years' experience managing and directing device and drug development...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Genzyme frustrates Icahn with new board nomination and renewed antitrust accusations
- US healthcare reform: painting the future for the pharma industry
- US FDA senior staff appointments reflect consumer advocacy and regulatory expertise
- India-linked private equity firm invests in ClinTec
COMMENT
Other Informa Comment
FEATURES
- Recipharm sees opportunity to ride wave of CDMO consolidation
- Connexios: Harnessing the Indian cost advantage in network biology
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
